What changed 10-Q

Item 5. Other Information

2023-11-13 compared with 2023-08-10 · 5 added, 9 removed, 11 unchanged (56% of the section changed)

OTHER INFORMATION

Certification

of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 *

Certification

of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2022 *

Certification

pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 **

Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 *

Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2022 *

Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 **

Inline XBRL Document Set

5 unchanged sentences

to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by

the undersigned thereunto duly authorized, on August 10, 2023.

the undersigned thereunto duly authorized, on November 13, 2023.

SUNSHINE BIOPHARMA, INC.

1 unchanged sentence

Camille Sebaaly

Chief Financial

Officer (principal financial and accounting officer)

Financial Officer (principal financial and accounting officer)

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.